Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.


Dr. Iltefat Hamzavi is a dermatologist who works at Henry Ford Hospital and Hamzavi/Dermatology Specialists. His work has a focus on vitiligo, photomedicine, and hidradenitis suppurativa. Within vitiligo his work has focused on improving phototherapy options for vitiligo patients. His group has also led North American efforts in developing surgical treatments for vitiligo. He has participated in developing the VASI score and updated scores as a way to measure treatment response for vitiligo patients. He is also one of the founders and Co-chair of the Global Vitiligo Foundation. This is a group which aims to improve the lives of vitiligo patients by supporting initiatives like the World Vitiligo Day and vitiligo research updates. He is a passionate metro Detroiter, husband, and father of 3.
Recording and Handouts from 2018 Integrative Dermatology Symposium.

The Integrative Dermatology Symposium focuses on new and emerging therapies, innovations, and best practices across disciplines in dermatology to improve dermatological patient care from an interdisciplinary approach.

Explore the disease mechanisms, immune pathways, and clinical features of vitiligo to strengthen diagnosis and treatment decisions.

Learn how to assess vitiligo disease activity in a 54-year-old patient using clinical indicators and practical evaluation tools.

Join expert dermatologists as they evaluate multiple cases of vitiligo from diagnosis to management.

This session will review how the presentation of vitiligo may be altered in skin of color, including physical and psychosocial impacts. The need to adjust therapeutic approaches when assessing those with darker skin afflicted with vitiligo will be reviewed.

This session will provide a practical scientific review on the immunology of vitiligo that will summarize the role of inflammation, genetics, and oxidative stress. The role of the JAK/TEC pathway will be emphasized. The psychosocial impact of vitiligo will be reviewed.

This session will review the clinical presentation of vitiligo and when to consider the use of systemic agents. The associated autoimmune, physical, and psychological co-morbidities will be reviewed. The clinical evidence for the use of JAK inhibition, such as topical JAK inhibitors, will be discussed.
